Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Deborah Stocken.

Newcastle AuthorsTitleYearFull text
Dr Stefan Siebert
Dr Arthur Pratt
Dr Deborah Stocken
Dr Miranda Morton
Amy Cranston
et al.
Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial2020
Professor Vinidh Paleri
Dr Joanne Patterson
Dr Nicolette Rousseau
Eoin Moloney
Professor Dawn Craig
et al.
Gastrostomy versus nasogastric tube feeding forchemoradiation patients with head and neck cancer:the TUBE pilot RCT2018
Dr Stuart McPherson
Dr Nina Wilson
Dr Dina Tiniakos
Dr Jennifer Wilkinson
Professor Alastair Burt
et al.
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis2017
Dr Henry Grantham
Dr Deborah Stocken
Professor Nick Reynolds
Doxycycline: A first-line treatment for bullous pemphigoid?2017
Dr Nigel Camilleri
Professor Dorothy Newbury-Birch
Dr Paul McArdle
Dr Deborah Stocken
Professor Ann Le Couteur
et al.
Innovations in Practice: A case control and follow-up study of "hard to reach' young people who suffered from multiple complex mental disorders2017
Amy Cranston
Dr Deborah Stocken
Elaine Stamp
Professor Ruth Plummer
Professor Sir John Burn
et al.
Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial.2017
Dr Lorraine McSweeney
James O'Hara
Dr Nicolette Rousseau
Dr Deborah Stocken
Professor Luke Vale
et al.
‘Thinking that somebody's going to delay [a tonsillectomy] for one to two years is quite horrifying really’: a qualitative feasibility study for the NAtional Trial of Tonsillectomy IN Adults (NATTINA Part 2)2016
Professor Vinidh Paleri
Dr Joanne Patterson
Dr Deborah Stocken
Mike Cole
Professor Luke Vale
et al.
A feasibility study incorporating a pilot randomised controlled trial of oral feeding plus pre-treatment gastrostomy tube versus oral feeding plus as-needed nasogastric tube feeding in patients undergoing chemoradiation for head and neck cancer (TUBE trial): study protocol2016
Dr Deborah Stocken
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study2016
Dr Stuart Little
Dr Thomas Chadwick
Dr Deborah Stocken
Catherine Brennand
Emerita Professor Sally Marshall
et al.
Recovery of hypoglycemia awareness in longstanding type 1 diabetes: A multicenter 2×2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose selfmonitoring (HypoCOMPaSS)2016
Dr Jess Dyson
Dr Nina Wilson
Dr Laura Jopson
Samantha Ducker
Dr Deborah Stocken
et al.
The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis2016
Gillian Watson
James O'Hara
Professor Paul Carding
Jan Lecouturier
Dr Deborah Stocken
et al.
TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial2016
Professor Peter Farr
Professor Nick Reynolds
Dr Deborah Stocken
Claire Macdonald
Dr Shyamal Wahie
et al.
An observer-blinded randomized controlled pilot study comparing localised psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of hand eczema2015
Dr Jean Adams
Louis Goffe
Professor Ashley Adamson
Joel Halligan
Dr Nicola O'Brien
et al.
Prevalence and socio-demographic correlates of cooking skills in UK adults: cross-sectional analysis of data from the UK National Diet and Nutrition Survey2015
Dr Deborah Stocken
REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial2015
Isabel Rubie
Dr Katie Haighton
James O'Hara
Dr Nicolette Rousseau
Dr Nick Steen
et al.
The NAtional randomised controlled Trial of Tonsillectomy IN Adults (NATTINA): a clinical and cost-effectiveness study: study protocol for a randomised control trial2015
Dr Deborah Stocken
Dr Kate Sumpter
Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study2014
Dr Stuart Little
Dr Thomas Chadwick
Dr Deborah Stocken
Catherine Brennand
Emerita Professor Sally Marshall
et al.
Recovery of Hypoglycemia Awareness in Long-Standing Type 1 diabetes: A Multicenter 2x2 Factorial Randomized Controlled Trial Comparing Insulin Pump with Multiple Daily Injections and Continuous with Conventional Glucose Self-Monitoring (HypoCOMPaSS)2014
Dr Stuart Little
Dr Thomas Chadwick
Dr Deborah Stocken
Catherine Brennand
Emerita Professor Sally Marshall
et al.
Response to Comment on Little et al. Recovery of Hypoglycemia Awareness in Long-standing Type 1 Diabetes: A Multicenter 2 x 2 Factorial Randomized Controlled Trial Comparing Insulin Pump With Multiple Daily Injections and Continuous With Conventional Glucose Self-monitoring (HypoCOMPaSS). Diabetes Care 2014;37:2114-21222014
Dr Deborah Stocken
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial2013
Dr Deborah Stocken
Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial2013
Dr Deborah Stocken
Phase 1 trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients2013
Dr Deborah Stocken
A Randomised Controlled Trial to Evaluate both the Role and the Optimal Fractionation of Radiotherapy in the Conservative Management of Early Breast Cancer2012
Richard Charnley
Dr Deborah Stocken
Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma. The ESPAC-3 Periampullary Cancer Randomized Trial2012
Dr Deborah Stocken
Dr Thamir Ismail
Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test2012
Dr Deborah Stocken
The value of source data verification in a cancer clinical trial2012
Dr Deborah Stocken
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-132011
Dr Deborah Stocken
Adjuvant Chemotherapy with Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection: a Randomized Controlled Trial2010
Dr Deborah Stocken
Statistical Modelling for the Prognostic Classification of Patients with Pancreatic Cancer for Optimisation of Treatment Allocation [PhD Thesis]2010
Dr Deborah Stocken
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials2009
Dr Deborah Stocken
ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma2009
Dr Thamir Ismail
Dr Deborah Stocken
Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme2009
Dr Deborah Stocken
Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer - subset analysis of the ESPAC-1 data2009
Dr Deborah Stocken
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer2009
Dr Deborah Stocken
Influence of Resection Margins and Treatment on Survival in Patients With Pancreatic Cancer: Meta-analysis of Randomized Controlled Trials2008
Dr Deborah Stocken
Modelling prognostic factors in advanced pancreatic cancer2008
Dr Deborah Stocken
A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin2007
Dr Deborah Stocken
Dr Thamir Ismail
Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients2007
Dr Deborah Stocken
The case for adjuvant chemotherapy in pancreatic cancer2006
Dr Deborah Stocken
Cationic Trypsinogen Mutations and Pancreatitis2005
Dr Deborah Stocken
Influence of Surgical Resection and Post-Operative Complications on Survival following Adjuvant Treatment for Pancreatic Cancer in the ESPAC-1 Randomized Controlled Trial2005
Dr Deborah Stocken
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer2005
Dr Deborah Stocken
A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer2004
Dr Deborah Stocken
A randomized phase II trial of neoadjuvant chemotherapy for patients with resectable pancreatic cancer: Gemcitabine alone vs. gemcitabine combined with cisplatin2004
Dr Deborah Stocken
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer2004
Dr Deborah Stocken
Cationic trypsinogen mutations and pancreatitis2004
Dr Deborah Stocken
Clinical and genetic characteristics of hereditary pancreatitis in Europe2004
Dr Deborah Stocken
ESPAC-1: final results of a European, randomized controlled trial to assess the roles of adjuvant chemotherapy and adjuvant chemoradiation in resectable pancreatic cancer2004
Dr Deborah Stocken
Long-term results of a phase II study of synchronous chemo radiotherapy in muscle invasive bladder cancer2004
Dr Deborah Stocken
Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer2004
Dr Deborah Stocken
The commercialisation of clinical research: who pays the piper, calls the tune?2004
Dr Deborah Stocken
A phase II irinotecan–cisplatin combination in advanced pancreatic cancer2003
Dr Deborah Stocken
Adjuvant therapy in pancreatic cancer: historical and current perspectives2003
Dr Deborah Stocken
Adjuvante und additive therapie beim pankreaskarzinom [Adjuvant and additive therapy for cancer of the pancreas]2003
Dr Deborah Stocken
Preoperative Mitomycin, Ifosfamide, and Cisplatin Followed by Esophagectomy in Squamous Cell Carcinoma of the Esophagus: Pathologic Complete Response Induced by Chemotherapy Leads to Long-Term Survival2003
Dr Deborah Stocken
Influence of resection margins on survival for patients with resectable pancreatic cancer treated with chemoradiation or chemotherapy within the European Study Group for Pancreatic Cancer 1 study2002
Dr Deborah Stocken
Influence of the type of surgery and surgical complications in the ESPAC-1 adjuvant trial2002
Dr Deborah Stocken
A phase I—II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer2001
Dr Deborah Stocken
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial2001
Dr Deborah Stocken
Combined Results from Three Phase II Trials of Neoadjuvant Chemotherapy in Operable Adenocarcinoma of the Oesophagus2001
Dr Deborah Stocken
Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial2001
Dr Stephanie Needham
Dr Deborah Stocken
Laparoscopic peritoneal lavage in staging gastric and oesophageal cancer2001
Amanda Gee
Dr Deborah Stocken
A randomised controlled trial to test a non-metallic deodorant used during a course of radiotherapy2000
Dr Deborah Stocken
Management guidelines for women with normal colposcopy after low grade cervical abnormalities: population study2000
Dr Deborah Stocken
Histologic and Immunologic Associations of an HPV16 Variant in LoSIL Smears1999
Dr Deborah Stocken
Adjuvant radiotherapy and follow-on chemotherapy in patients with pancreatic cancer. Results of the UK Pancreatic Cancer Group Study (UKPACA-1)1998